Who backs Cytrellis?
9 investors| Investor | Type |
|---|---|
| D1 Capital Partners | Hedge fund |
| ARCH Venture Partners | Venture capital |
| Venrock | Venture capital |
| Sands Capital | Growth equity |
| Biomatics Capital | Venture capital |
| Mass General Brigham Innovation | — |
| Massachusetts Life Sciences Center | — |
| Merz Pharma | — |
| PFM Health Sciences | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Cytrellis investors
9 investors are on record for Cytrellis, including D1 Capital Partners, ARCH Venture Partners, Venrock and Sands Capital. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 growth equity firm. The Series C in Jan 2021 drew 4 investors.
Free account
More of Cytrellis with a free account
- ·Watch Cytrellis: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 9 firms already write checks for companies like Cytrellis in other devices and supplies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View